SEC 13F Intelligence

AN2 THEREAPEUTICS INC

CUSIP 373261056

An2 Thereapeutics Inc has 1 institutional holders in Filings Flow’s 13F database, together reporting 371.8K shares worth $1M as of Q1 2026.

Institutional Holders
1
Q1 2026
Reported Value
$1M
Ticker
unmapped
private placement or foreign
Quarters Tracked
2

Ownership Trend

Institutional holders
Q4 ’25: 1Q4 ’25Q1 ’26: 1Q1 ’26filingsflow.com
Total reported value
Q4 ’25: $429,518Q4 ’25Q1 ’26: $1MQ1 ’26filingsflow.com

Holders

Manager% of PortfolioValueSharesQuarter
Aldebaran Capital, LLC$131M AUM0.97%$1M371.8KQ1 2026

Holdings are reported up to 45 days after quarter end. Share counts are as filed and not adjusted for stock splits.